<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40796241</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-9645</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Aug</Month><Day>12</Day></PubDate></JournalIssue><Title>European heart journal</Title><ISOAbbreviation>Eur Heart J</ISOAbbreviation></Journal><ArticleTitle>Coronary function testing vs angiography alone to guide treatment of angina with non-obstructive coronary arteries: the ILIAS ANOCA trial.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">ehaf580</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/eurheartj/ehaf580</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Invasive coronary function testing (CFT) identifies coronary vasomotor disorders in up to 90% of patients with angina with non-obstructive coronary arteries (ANOCA). The ILIAS ANOCA trial hypothesized that routine ad hoc CFT would be feasible, safe, and effective in providing an early, comprehensive diagnosis. Additionally, it was anticipated that combining CFT with a disease-specific treatment protocol would significantly improve quality of life in ANOCA patients compared with standard care.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">After excluding patients with obstructive coronary artery disease (CAD) during clinically indicated invasive coronary angiography (ICA), eligible patients underwent CFT and were randomized to either the standard care group, where CFT results remained blinded, or the intervention group, where CFT results were disclosed along with a tailored medical therapy protocol. The primary outcome was the mean difference in the within-subject change in Seattle Angina Questionnaire summary score (SAQSS) between groups from baseline to a follow-up of 6&#x2005;months. The trial is registered with the International Clinical Trials Registry Platform (NL-OMON20739).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 255 patients consented, of whom 153 patients (60%) without CAD underwent CFT and were randomized 1:1 to the standard care (n = 76) or intervention group (n = 77). All CFT procedures were successful without adverse events. A vasomotor disorder was identified in 120 patients (78%). At 6-month follow-up, the SAQSS improved significantly in the intervention group compared with the control group, with an intervention effect of 9.4&#x2005;units (95% confidence interval 3.9-14.9, P = .001). There were no major adverse cardiac events at the 6-month follow-up.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Routine CFT during the initial ICA was feasible, safe, and had high diagnostic yield. Implementing a pragmatic CFT protocol combined with a disease-specific treatment protocol significantly improved disease-related quality of life in patients with ANOCA compared with standard care.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boerhout</LastName><ForeName>Coen K M</ForeName><Initials>CKM</Initials><Identifier Source="ORCID">0000-0003-1515-9623</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Amsterdam University Medical Center, Location AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Namba</LastName><ForeName>Hanae F</ForeName><Initials>HF</Initials><Identifier Source="ORCID">0009-0009-1107-2513</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Amsterdam University Medical Center, Location AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Tommy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HartKliniek Rijswijk, Rijswijk, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HartKliniek Bilthoven, Bilthoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beijk</LastName><ForeName>Marcel A M</ForeName><Initials>MAM</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Amsterdam University Medical Center, Location AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damman</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-9284-7967</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meuwissen</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5421-5205</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Amphia Hospital, Breda, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ong</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2253-2828</Identifier><AffiliationInfo><Affiliation>Department of Cardiology and Angiology, Robert Bosch Krankenhaus, Stuttgart, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sechtem</LastName><ForeName>Udo</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Angiology, Robert Bosch Krankenhaus, Stuttgart, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Appelman</LastName><ForeName>Yolande</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-5241-7105</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Amsterdam University Medical Center, Location VUMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berry</LastName><ForeName>Colin</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4547-8636</Identifier><AffiliationInfo><Affiliation>British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Golden Jubilee National Hospital, Clydebank, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Escaned</LastName><ForeName>Javier</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4932-0112</Identifier><AffiliationInfo><Affiliation>Cardiology Department, Hospital Cl&#xed;nico San Carlos, IDISSC Universidad Complutense de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lerman</LastName><ForeName>Amir</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9446-5313</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henry</LastName><ForeName>Timothy D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>The Carl and Edyth Lindner Research Center at the Christ Hospital, Cincinnati, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Harst</LastName><ForeName>Pim</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-2713-686X</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delewi</LastName><ForeName>Ronak</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Amsterdam University Medical Center, Location AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piek</LastName><ForeName>Jan J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Amsterdam University Medical Center, Location AMC, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van de Hoef</LastName><ForeName>Tim P</ForeName><Initials>TP</Initials><Identifier Source="ORCID">0000-0003-0682-0619</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Philips IGDT</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J</MedlineTA><NlmUniqueID>8006263</NlmUniqueID><ISSNLinking>0195-668X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Angina with non-obstructive coronary arteries</Keyword><Keyword MajorTopicYN="N">Coronary function testing</Keyword><Keyword MajorTopicYN="N">Coronary microvascular dysfunction</Keyword><Keyword MajorTopicYN="N">Coronary vasospasm</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>13</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>13</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>12</Day><Hour>20</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40796241</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehaf580</ArticleId><ArticleId IdType="pii">8232491</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>